Zymeworks (ZYME) Gains from Investment Securities (2021 - 2024)

Zymeworks (ZYME) has 4 years of Gains from Investment Securities data on file, last reported at -$1.2 million in Q2 2024.

• For the quarter ending Q2 2024, Gains from Investment Securities changed N/A year-over-year to -$1.2 million; the trailing twelve-month figure through Mar 2025 stood at -$1.2 million (down 107.03% YoY), and the FY2024 full-year result was -$1.9 million, down 398.1% from the prior year.
• Gains from Investment Securities declined to -$1.2 million in Q2 2024, from -$700000.0 in the prior quarter.
• In the past five years, Gains from Investment Securities ranged from a high of $499000.0 in Q1 2023 to a low of -$1.2 million in Q2 2024.
• A 4-year average of -$188000.0 and a median of -$168000.0 in 2023 frame the typical range for Gains from Investment Securities.
• Peak annual rise in Gains from Investment Securities reached 240.28% in 2024, while the deepest fall reached 240.28% in 2024.
• Tracing ZYME's Gains from Investment Securities over 4 years: stood at $182000.0 in 2021, then tumbled by 237.36% to -$250000.0 in 2022, then soared by 219.6% to $299000.0 in 2023, then plunged by 493.98% to -$1.2 million in 2024.
• Business Quant data shows ZYME's Gains from Investment Securities at -$1.2 million in Q2 2024, -$700000.0 in Q1 2024, and $299000.0 in Q4 2023.